Peer-Reviewed Papers ▶ Trial Analysis

Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer

  Back

https://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/66029ae7f7a26a7b9c6a85aa_FZOipUcWYAEhH8S.png

Read also



Generalized pairwise comparison methods to analyse (non)prioritized composite endpoints
Methodological papers
Generalized pairwise comparison methods to analyse (non)prioritized composite endpoints
READ MORE →
 Generalized pairwise comparisons of prioritized outcomes are a powerful and patient-centric analysis of multi-domain scores
Trial Designs
Generalized pairwise comparisons of prioritized outcomes are a powerful and patient-centric analysis of multi-domain scores
READ MORE →
 Generalized pairwise comparisons of prioritized outcomes in the two-sample problem
Methodological papers
Generalized pairwise comparisons of prioritized outcomes in the two-sample problem
READ MORE →
 Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: a simulation study
Methodological papers
Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: a simulation study
READ MORE →